Articles

Articles 5,613 registres trobats  inicianterior555 - 564següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
555.
14 p, 8.0 MB Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy / Reyngoudt, Harmen (NMR Laboratory) ; Smith, Fiona Elizabeth (Newcastle University) ; Caldas de A. Araújo, Ericky (NMR Laboratory) ; Wilson, Ian (Newcastle University) ; Fernandez-Torron, Roberto (Hospital de Donostia (Sant Sebastià, País Basc)) ; James, Meredith K. (Newcastle University) ; Moore, Ursula (Newcastle University) ; Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Marty, Benjamin (NMR Laboratory) ; Azzabou, Noura (NMR Laboratory) ; Gordish-Dressman, Heather (George Washington University) ; Rufibach, Laura E. (The JAIN Foundation) ; Hodgson, Tim (Newcastle University) ; Wallace, Dorothy (Newcastle University) ; Ward, Louise (Newcastle University) ; Boisserie, Jean Marc (NMR Laboratory) ; Le Louër, Julien (NMR Laboratory) ; Hilsden, Heather (Newcastle University) ; Sutherland, Helen (Newcastle University) ; Canal, Aurélie (Institute of Myology) ; Hogrel, J.Y (Institut de Myologie (París, França)) ; Jacobs, Marni (George Washington University) ; Stojkovic, Tanya (Institut deMyologie (París, França)) ; Bushby, Kate (Newcastle University) ; Mayhew, Anna G. (Newcastle University) ; Straub, Volker (Newcastle University) ; Carlier, Pierre G. (University Paris-Saclay) ; Blamire, Andrew (Newcastle University) ; Universitat Autònoma de Barcelona
Natural history studies in neuromuscular disorders are vital to understand the disease evolution and to find sensitive outcome measures. We performed a longitudinal assessment of quantitative magnetic resonance imaging (MRI) and phosphorus magnetic resonance spectroscopy (P MRS) outcome measures and evaluated their relationship with function in lower limb skeletal muscle of dysferlinopathy patients. [...]
2022 - 10.1002/jcsm.12987
Journal of Cachexia, Sarcopenia and Muscle, Vol. 13 Núm. 3 (june 2022) , p. 1850-1863  
556.
23 p, 3.1 MB Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations : SABINA Findings From Europe and North America / Quint, Jennifer K. (Imperial College London) ; Arnetorp, Sofie (Payer Analytics. AstraZeneca) ; Kocks, Janwillem W.H. (University Medical Center Groningen) ; Kupczyk, Maciej (Karolinska Institutet (Estocolm, Suècia)) ; Nuevo, Javier (Evidence Generation. AstraZeneca) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Cabrera, Claudia (BioPharmaceuticals Medical (Evidence). AstraZeneca) ; Raherison-Semjen, Chantal (Bordeaux University) ; Walker, Brandie (University of Calgary) ; Penz, Erika (University of Saskatchewan) ; Gilbert, Ileen (Medical Affairs. AstraZeneca) ; Lugogo, Njira Lucia (University of Michigan) ; van der Valk, Ralf J.P. (Medical Affairs. AstraZeneca) ; Fong, Andrew ; Qian, Christina ; Fabry-Vendrand, Caroline ; Touboul, Chantal ; Brzostek, Dorota ; Maslova, Ekaterina ; Surmont, Filip ; Goike, Helena ; Gandhi, Hitesh ; Korevaar, J.C. ; Tkacz, Joseph ; Johnston, Karissa ; Peres da Costa, Keith ; van Dijk, L. ; Vervloet, M. ; Pollack, Michael ; Hernandez, Paul ; Boarino, S. ; Noorduyn, Stephen G. ; Beekman-Hendricks, Wendy ; Weesie, Y.M. ; Universitat Autònoma de Barcelona
Expert national/global asthma management recommendations raise the issue whether a safe threshold of short-acting beta-2 agonist (SABA) use without concomitant inhaled corticosteroids (ICS) exists. To examine SABA and maintenance therapy associations with severe asthma exacerbations across North America and Europe. [...]
2022 - 10.1016/j.jaip.2022.02.047
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10 Núm. 9 (september 2022) , p. 2297-2309.e10  
557.
11 p, 808.4 KB SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) / Remon, Jordi (HM Hospitales) ; Bernabé, Reyes (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Diz Taín, Pilar (Hospital Universitario de León) ; Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ; González-Larriba, J.L. (Hospital Universitario Clínico San Carlos (Madrid)) ; Lázaro, Martín (Hospital Álvaro Cunqueiro (Vigo)) ; Mielgo-Rubio, X. (Hospital Universitario Fundación Alcorcón) ; Sánchez Hernández, Alfredo (Consorci Hospitalari Provincial de Castelló) ; Sullivan, Ivana (Institut d'Investigació Biomèdica Sant Pau) ; Massuti, Bartomeu (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Universitat Autònoma de Barcelona
Thymic epithelial tumours (TET) represent a heterogeneous group of rare malignancies that include thymomas and thymic carcinoma. Treatment of TET is based on the resectability of the tumour. If this is considered achievable upfront, surgical resection is the cornerstone of treatment. [...]
2022 - 10.1007/s12094-022-02788-w
Clinical & Translational Oncology, Vol. 24 Núm. 4 (april 2022) , p. 635-645  
558.
9 p, 1013.2 KB Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis : a post hoc pooled analysis of AMAGINE-2 and -3 / Reich, Kristian (University Medical Center Hamburg-Eppendorf) ; Iversen, L. (Aarhus University Hospital (Aarhus, Dinamarca)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Lambert, Jo (Ghent University) ; Mrowietz, Ulrich (University Medical Center Schleswig-Holstein) ; Kaplan Saday, K. (LEO Pharma A/S) ; Warren, R. B. (University of Manchester) ; Universitat Autònoma de Barcelona
Brodalumab is a monoclonal antibody that blocks multiple interleukin (IL)-17 family cytokines by binding to the shared A subunit of the IL-17 receptor. In Phase 3 trials, brodalumab provided high levels of skin clearance through 52 weeks in patients with moderate-to-severe psoriasis and was generally well tolerated. [...]
2022 - 10.1111/jdv.18068
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 8 (august 2022) , p. 1275-1283  
559.
11 p, 1.4 MB A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map / Pottie, Kevin (Western University) ; Smith, Maureen (Cochrane Consumer Network Executive) ; Matthews, Micayla (McMaster University (Canadà)) ; Santesso, Nancy (McMaster University (Canadà)) ; Magwood, Olivia (University of Ottawa) ; Kredo, Tamara (Stellenbosch University) ; Scott, Sarah (McMaster University (Canadà)) ; Bayliss, Kerin (National Institute for Health and Care Excellence) ; Saad, Ammar (University of Ottawa) ; Haridas, Rinila (University of Ottawa) ; Detambel, Nicole (McMaster University (Canadà)) ; Motilall, Ashley (McMaster University (Canadà)) ; Tan, Yvonne (University of Ottawa) ; Steinberg, Sally (Lancaster High School) ; Litynska, Justyna (Evidence Prime. Inc.) ; Dietl, Bart (Evidence Prime. Inc.) ; Iorio, Alfonso (McMaster University (Canadà)) ; Reveiz, Ludovic (Pan American Health Organization) ; Welch, Vivian (University of Ottawa) ; Klugar, Miloslav (Czech National Centre for Evidence-Based Healthcare and Knowledge Translation Brno) ; Mbuagbaw, Lawrence (Cochrane South Africa) ; Rojas-Reyes, Maria Ximena (Institut d'Investigació Biomèdica Sant Pau) ; Florez, Ivan D (Clinica Las Americas-AUNA) ; Lotfi, Tamara (McMaster University (Canadà)) ; Qaseem, Amir (American College of Physicians) ; Mathew, Joseph L. (Postgraduate Institute of Medical Education and Research) ; Akl, Elie A (American University of Beirut) ; Tugwell, Peter (University of Ottawa) ; Schünemann, Holger J. (McMaster University (Canadà)) ; Universitat Autònoma de Barcelona
To develop a digital communication tool to improve the implementation of up-to-date COVID-19 recommendations. Specifically, to improve patient, caregiver and public understanding of healthcare recommendations on prevention, diagnoses and treatment. [...]
2022 - 10.1016/j.jclinepi.2022.04.012
Journal of Clinical Epidemiology, Vol. 148 (august 2022) , p. 104-114  
560.
9 p, 751.0 KB Role of Pediatric Ureteral Access Sheath and Outcomes Related to Flexible Ureteroscopy and Laser Stone Fragmentation : A Systematic Review of Literature / Ripa, Francesco (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Tokas, Theodoros (Training and Research in Urological Surgery and Technology (T.R.U.S.T.) Group) ; Griffin, Stephen (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Ferretti, Stefania (Hospital and University of Parma) ; Bujons, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Somani, Bhaskar K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Universitat Autònoma de Barcelona
Flexible ureteroscopy and laser lithotripsy (FURSL) represent a good treatment option for pediatric urolithiasis. Scarce evidence is available about the safety and efficacy of the concomitant use of a ureteral access sheath (UAS) in the setting of pediatric ureteroscopy (URS). [...]
2022 - 10.1016/j.euros.2022.09.012
European Urology Open Science, Vol. 45 (november 2022) , p. 90-98  
561.
6 p, 420.6 KB Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model / Queiro, Ruben (Universidad de Oviedo) ; Seoane-Mato, Daniel (Sociedad Española de Reumatologia) ; Laiz, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Agirregoikoa, Eva Galíndez (Hospital de Basurto (Bilbao, Biscaia)) ; Montilla, Carlos (Hospital Universitario de Salamanca) ; Park, Hye-Sang (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Pinto-Tasende, Jose A. (Complejo Hospitalario Universitario de A Coruña) ; Bethencourt Baute, Juan José (Hospital Universitario de Canarias (La Laguna)) ; Ibáñez, Beatriz Joven (Hospital Universitario 12 de Octubre) ; Toniolo, Elide (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ; García, Ana Serrano (Universidad Autónoma de Madrid) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Juanola, Xavier (Hospital Universitari de Bellvitge) ; Gratacós, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Rodriguez-Moreno, Jesús (Hospital Universitari de Bellvitge) ; Notario, Jaime (Hospital Universitari de Bellvitge) ; López-Ferrer, Anna (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Cuervo, Andrea (Hospital Clínic i Provincial de Barcelona) ; Alsina Gibert, Mercè (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
To evaluate which patient and disease characteristics are associated with the perception of high-impact disease (PsAID ≥4) in recent-onset psoriatic arthritis. We performed a multicenter observational prospective study (2-year follow-up, regular annual visits). [...]
2022 - 10.1016/j.semarthrit.2022.152097
Seminars in Arthritis and Rheumatism, Vol. 57 (december 2022) , p. 152097  
562.
10 p, 1.8 MB Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis / Reich, Kristian (University Medical Center Hamburg-Eppendorf) ; Conrad, Curdin (University Hospital Lausanne CHUV) ; Kristensen, Lars Erik (Lund University) ; Smith, Saxon D. (The University of Sydney) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Rich, Phoebe (Oregon Dermatology and Research Center) ; Sapin, Christophe (Eli Lilly and Company) ; Holzkaemper, Thorsten (Eli Lilly and Company) ; Koppelhus, Uffe (Eli Lilly and Company) ; Schuster, Christopher (Medical University of Vienna) ; Universitat Autònoma de Barcelona
Nail psoriasis (NP) is common and of high importance in patients with psoriasis. Complete resolution of NP at week 24‒26 is an unambiguous nail outcome accessible for indirect treatment comparison of biologics. [...]
2022 - 10.1080/09546634.2021.1892024
Journal of Dermatological Treatment, Vol. 33 Núm. 3 (2022) , p. 1652-1660  
563.
12 p, 468.2 KB In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida : A European Study / Quindós, Guillermo (Universidad del País Vasco) ; Miranda-Cadena, Katherine (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; San-Millán, Rosario (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Borroto-Esoda, Katyna ; Cantón, Emilia (Hospital Universitari i Politècnic La Fe (València)) ; Linares-Sicilia, María José (Universidad de Córdoba) ; Hamprecht, Axel (University of Oldenburg) ; Montesinos, Isabel (Hospital Universitario Basurto BioCruces Bizkaia) ; Tortorano, Anna Maria (Università degli Studi di Milano) ; Prigitano, Anna (Università degli Studi di Milano) ; Vidal-García, Matxalen (Hospital Universitario Basurto BioCruces Bizkaia) ; Marcos-Arias, Cristina (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Guridi, Andrea (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Sanchez-Reus, Ferran (Institut d'Investigació Biomèdica Sant Pau) ; Machuca-Bárcena, Jesús (Universidad de Cádiz) ; Rodríguez-Iglesias, Manuel Antonio (Universidad de Cádiz) ; Martín-Mazuelos, Estrella (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Castro-Méndez, Carmen (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; López-Soria, Leyre (Hospital Universitario de Cruces and BioCruces Bizkaia) ; Ruiz-Gaitán, Alba (Instituto de Investigación Sanitaria. Hospital Universitario y Politécnico La Fe) ; Fernandez-Rivero, Marcelo (Hospital Universitari i Politècnic La Fe (València)) ; Lorenzo, Damaris (Universitat Rovira i Virgili) ; Capilla, Javier (Universitat Rovira i Virgili) ; Rezusta, Antonio ; Pemán, Javier (Hospital Universitari i Politècnic La Fe (València)) ; Guarro, Josep (Universitat Rovira i Virgili) ; Pereira, Joana (University of Minho) ; Pais, Célia (University of Minho) ; Romeo, Orazio (University of Messina) ; Ezpeleta, Guillermo (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Jauregizar, Nerea (Universidad del País Vasco) ; Angulo, David ; Eraso, Elena (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Universitat Autònoma de Barcelona
Ibrexafungerp (SCY-078) is the newest oral and intravenous antifungal drug with broad activity, currently undergoing clinical trials for invasive candidiasis. The aim of this study was to assess the in vitro activity of ibrexafungerp and comparators against a collection of 434 European blood isolates of Candida. [...]
2022 - 10.3389/fcimb.2022.906563
Frontiers in cellular and infection microbiology, Vol. 12 (16 2022) , p. 906563  
564.
11 p, 265.1 KB Safinamide in clinical practice : A Spanish multicenter cohort study / Martí-Andrés, Gloria (Clínica Universidad de Navarra) ; Jiménez-Bolaños, Rayco (Hospital Universitario Insular de Gran Canaria) ; Arbelo, José Matías (Hospital Universitario Insular de Gran Canaria) ; Pagonabarraga Mora, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Duran-Herrera, Carmen (Hospital Universitario de Badajoz) ; Valenti-Azcarate, Rafael (Clínica Universidad de Navarra) ; Luquin, Maria-Rosario (Clínica Universidad de Navarra) ; Universitat Autònoma de Barcelona
Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson's Disease (PD) patients with a potential benefit on non-motor symptoms (NMS). A retrospective multicenter cohort study was conducted, in which the clinical effect of safinamide on both motor and NMS was assessed by the Clinical Global Impression of Change scale. [...]
2019 - 10.3390/brainsci9100272
Brain sciences, Vol. 9 Núm. 10 (october 2019) , p. 272  

Articles : 5,613 registres trobats   inicianterior555 - 564següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.